UptalPatel United States

Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Precise Phenotyping and Treatment
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comSanatorio Parque SAArgentina
  • Deciphering the IGAN Cell Atlas
    JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
  • Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
    MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
  • CART-T
    JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio
  • New Targets to Reduce the Burden of Rare Kidney Diseases
    LauraMariani Speaker University of MichiganUnited States
  • Q and A
Hall C4
10:30 a.m.
11 a.m.
Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy
JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria
Hall A
3 p.m.
4 p.m.
New Tools to Study Kidney Disease
RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina
ReikoInagi Chairperson The University of Tokyo Graduate School of MedicineJapan
  • Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology
    LauraPerin Speaker LPerin@chla.usc.eduUnited States
  • Spatial Metabolomics of Kidney Disease
    TonRabelink Speaker a.j.rabelink@lumc.nlLUMCNetherlands
  • Constructing an Epigenetic Network for Diabetic Nephropathy
    Sam El-Osta Speaker sam.el-osta@baker.edu.auBaker Heart and Diabetes InstituteAustralia
  • Q and A
Hall E
4 p.m.
4:30 p.m.
Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker uptal@hibio.comUnited States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
Kidney Transplantation: State of the Art. ISN-TTS Joint Session
CarlosDiaz Chairperson cdiaz@cemic.edu.arSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC.Argentina
GermaineWong Chairperson University of SydneyAustralia
MarianoArriola Chairperson marianoarriola@hotmail.comSAT, SAN, Facultad de Medicina (UNL)Argentina
  • Quality and Safety in Kidney Transplantation
    WanessaClemente Speaker wanclemente@yahoo.com.brUniversidade Federal de Minas GeraisBrazil
  • Machine Perfusion of the Kidney
    HenryPleass Speaker henry.pleass@sydney.edu.auSpecialty of Surgery, Westmead Hospital, UniversitAustralia
  • Menopause and Kidney Transplantation
    SofiaAhmed Speaker sofia.ahmed@ahs.caUniversity of AlbertaCanada
  • Q and A
Hall D

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
Hot Digests of Kidney Inflammation and Immunity: ISN-JSN Joint Session
AlejandraQuevedo Smuclir Chairperson alejandra.s.quevedo@gmail.comSANArgentina
CarmenTzanno Branco Martins Chairperson tzanno@gmail.comSLANH, ISNBrazil
SaoriNishio Chairperson saorin@med.hokudai.ac.jpJapan
  • Update of Glomerulonephritis
    FernandoFervenza Speaker fervenza.fernando@mayo.eduMayo ClinicUnited States
  • Inflammation and Metabolic Kidney Disease
    JunWada Speaker junwada@okayama-u.ac.jpOkayama UniversityJapan
  • A Novel Treatment Targeting Kidney Inflammation
    Maria JoséSoler Romeo Speaker Hospital del Vall d´HebronSpain
  • Controlling Kidney Inflammation Through the Nervous System
    ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpDivision of Nephrology and Endocrinology, the University of Tokyo HospitalJapan
  • Q and A
Hall C3
11 a.m.
12 p.m.
Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel)
Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala
MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Generative AI Revolution in Medicine
    MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel
  • Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh)
    Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh
Hall A
3 p.m.
4 p.m.
Late Breaking Clinical Trials Session
AlessiaFornoni Chairperson United States
MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication University of Leicester, Leicester, UKUnited Kingdom
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance
Hall A
Transplant-Onconephrology
DarioRoccatello Chairperson dario.roccatello@unito.itItaly
GayatriNair Chairperson gnair1@northwell.eduNorthwell Health, NYUnited States
MarianoArriola Chairperson marianoarriola@hotmail.comSAT, SAN, Facultad de Medicina (UNL)Argentina
  • Use of Immunotherapy in Patients With Organ Transplants
    NaokaMurakami Speaker nmurakami1@bwh.harvard.eduBrigham and Women\'s Hospital, Harvard Medical SUnited States
  • Transplantation Outcomes in Recipients with History of Cancer
    GermaineWong Speaker University of SydneyAustralia
  • Novel Strategies for Enhanced Organ Preservation during Machine Perfusion
    TobiasHuber Speaker University Medical Center Hamburg-EppendorfGermany
  • Q and A
Hall E
4:30 p.m.
5:30 p.m.
Designing Smart Clinical Trials
DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom
  • Patients Subphenotyping: The Example of Diabetic Kidney Disease
    John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
  • Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
    LauraMariani Speaker University of MichiganUnited States
  • Targeted Approaches in Clinical Trial Design
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall D

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
Clinical Management of Glomerulonephritis (GN)
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico
ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina
  • Updates on IgAN Management
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Membranous GN Classification and Management
    PierreRonco Speaker Hôpital TenonFrance
  • MPGN Updates
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
  • Q and A
Hall A
12:30 p.m.
1:30 p.m.
Rare and Orphan Diseases
AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States
RobertaFenoglio Chairperson roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly
VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina
  • Alport Spectrum Disorders (Genetics)
    MoumitaBarua Speaker moumita.barua@uhn.caCanada
  • Genetics of Nephrotic Syndrome
    SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduColumbia UniversityUnited States
  • Lupus Nephritis Transcriptomics Across Time and Space
    AnaMalvar Speaker avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina
  • Q and A
Hall E

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
Renal Pathology Course: New Insights in Glomerular Disease: Part 1
CarmenAvila Casado Chairperson Canada
ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina
WesamIsmail Chairperson wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt
  • Updates in Genetic Testing in Renal Disease
    DanicaGalešić Ljubanović Speaker danica.ljubanovic@mef.hrUniversity of Zagreb, School of Medicine, Department of Pathology and Dubrava University Hospital, Zagreb, CroatiaCroatia
  • Classification of Lupus
    AgnesFogo Speaker United States
  • New Insights in Membranous Nephropathy
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Amyloidosis Update
    WesamIsmail Speaker wesam_ismail@yahoo.comHead of Pathology Department, Beni Suef UniversityEgypt
  • Q and A
Hall C1
Primer Course in Glomerular Disease: A Case-Based Approach: Foundation in Glomerular Diseases & Rapidly Progressive Glomerulonephritis
AdrianLiew Chairperson Mount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom
  • Histophysiology of the Glomerulus
    SoniaChicano Speaker sonialchicano@yahoo.comISNPhilippines
  • Overview of Immunosuppression
    DanaRizk Speaker drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
  • Genetic Testing in Glomerular Diseases
    KeishaGibson Speaker keisha_gibson@med.unc.eduUniversity of North Carolina at Chapel Hill, USAUnited States
  • Approach to RPGN
    ArennJauhal Speaker Arenn.Jauhal@uhn.caCanada
  • Case Presentation and Discussion 1
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
Hall E
11:30 a.m.
1:30 p.m.
Primer Course in Glomerular Disease: A Case-Based Approach: Nephrotic Syndrome
AdrianLiew Chairperson Mount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom
  • Approach to Nephrotic Syndrome
    Chee KayCheung Speaker ckc15@leicester.ac.ukUniversity of LeicesterUnited Kingdom
  • Case Presentation and Discussion 2
    MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
  • Case Presentation and Discussion 3
    KeishaGibson Speaker keisha_gibson@med.unc.eduUniversity of North Carolina at Chapel Hill, USAUnited States
  • Case Presentation and Discussion 4
    HeatherReich Speaker University of Toronto, University Health NetworkCanada
Hall E
1 p.m.
2:30 p.m.
Sharing Expertise to Support the Set-up of Renal Registries: The Global Situation and Inspiration from Established Registries in Latin America: Part 1
FergusCaskey Chairperson University of Bristol, UKUnited Kingdom
MariaPippias Chairperson University of BristolUnited Kingdom
  • Welcome
    MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan
  • Introduction of SharE-RR
    FergusCaskey Speaker University of Bristol, UKUnited Kingdom
  • Introduction of SharE-RR Toolkit
    MariaPippias Speaker University of BristolUnited Kingdom
  • Current State of Registries Worldwide, 2023 ISN-GKHA
    AminuBello Speaker aminu1@ualberta.caUniversity of AlbertaCanada
  • The History of Renal Registries In Latin America: 1950 - Current (Including PAHO Collaboration)
    MariaGonzalez Speaker registro@slanh.netSLANHUruguay
  • The Argentinian Renal Registry
    GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
Sala 1
2:15 p.m.
4:15 p.m.
Primer Course in Glomerular Disease: A Case-Based Approach: Nephritic Syndrome
AdrianLiew Chairperson Mount Elizabeth Novena Hospital, SingaporeSingapore
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
HernánTrimarchi Chairperson HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom
  • Approach to Nephritic Syndrome
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Case Presentation and Discussion 5
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Case Presentation and Discussion 6
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Case Presentation and Discussion 7
    AdrianLiew Speaker Mount Elizabeth Novena Hospital, SingaporeSingapore
Hall E
4:30 p.m.
6 p.m.
WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina)
  • ISN President's Address
    MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan
  • Tribute to Stewart Cameron
  • Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen
  • Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair
    GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
    JorgeRico Speaker jorgericof@yahoo.comColombia
    MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina
  • Welcome by Minister of Health for Buenos Aries Dr Fern
  • Welcome by SPWG Chair Alessia Fornoni
    AlessiaFornoni Speaker United States
  • The Origin of the Universe
    DanielDe Florian Speaker deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina
  • Acceptance Speech: Hamburger Award
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
Hall A